Skip to content

Clinical trials

Phase 3 Venous Thrombosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Venous Thrombosis Phase: Phase 3 Country / region: United States Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20051
20065
20075
20084
20093
20101
20122
20141
20152
20173
20181
20222
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated5
Recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb5
Sanofi5
Bayer3
Daiichi Sankyo3
Regeneron Pharmaceuticals3
ARCA Biopharma, Inc.2
Academic and Community Cancer Research United2
Anthos Therapeutics, Inc.2
Healthpoint1
Johns Hopkins All Children's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Venous Thrombosis38
Pulmonary Embolism20
Venous Thromboembolism17
Thrombosis8
Neoplasms5
Postthrombotic Syndrome3
Thromboembolism3
Embolism2
Intracranial Thrombosis2
Neoplasm Metastasis2

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.